神经保护
大麻素受体
大麻素
神经毒性
神经科学
神经炎症
阿那达胺
内大麻素系统
药理学
神经退行性变
医学
生物
受体
疾病
内科学
毒性
兴奋剂
作者
Yosef Sarne,Raphael Mechoulam
出处
期刊:Cns & Neurological Disorders-drug Targets
[Bentham Science Publishers]
日期:2005-11-25
卷期号:4 (6): 677-684
被引量:132
标识
DOI:10.2174/156800705774933005
摘要
Cannabinoids, such as the delta9-tetrahydrocannabinol (THC), present in the cannabis plant, as well as anandamide and 2-arachidonoyl glycerol, produced by the mammalian body, have been shown to protect the brain from various insults and to improve several neurodegenerative diseases. The current review summarizes the evidence for cannabinoid neuroprotection in vivo, and refers to recent in vitro studies, which help elucidate possible molecular mechanisms underlying this protective effect. Some of these mechanisms involve the activation of CB1 and CB2 cannabinoid receptors, while others are not dependent on them. In some cases, protection is due to a direct effect of the cannabinoids on neuronal cells, while in others, it results from their effects on non-neuronal elements within the brain. In many experimental set-ups, cannabinoid neurotoxicity, particularly by THC, resides side by side with neuroprotection. The current review attempts to shed light on this dual activity, and to dissociate between the two contradictory effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI